Umbilical Cord Blood Transplantation: Clinical Challenges
Journal Title: International Journal of Stem Cell Research and Transplantation (IJST) - Year 2015, Vol 3, Issue 7
Abstract
Umbilical cord blood transplantation (UCBT) is becoming a salvage treatment in lieu of bone marrow or peripheral blood stem cell transplantation in patients with hematological disorders who lack human leucocyte antigen (HLA) identical stem cell donor. Additionally, this procedure has demonstrated reduced recurrent acute and chronic graft-versus-host disease, reduced relapse rates, long-term immunological recovery and comparable overall survival when compared with other unrelated allogeneic hematopoietic stem cell transplantation. UCBT is further elucidated by its easy procurement, expeditious availability and more tolerance for HLA mismatches. Discerningly, UCBT is followed by notable delays in the rates and kinetics of neutrophil and platelet engraftment and higher transplant related mortality. This is related in part to the inherently lessened number of hematopoietic stem and progenitor cells in UCB grafts. Several strategies have been assayed to overcome relatively limited number of stem cells, such as multiple UCB transplants and ex vivo expansion of HSCs. In this review, we have compiled the current clinical research investigations to provide reader with a brief glimpse into the remarkable potential UCB possess for transplantation.
Authors and Affiliations
Gurudutta Gangenahalli
Keywords
Related Articles
- EP ID EP197109
- DOI 10.19070/2328-3548-1500023
- Views 108
- Downloads 0
Investigation of Isolating of Human Mesenchymal Stem Cells From Umbilical Cord Blood and Labeling them with 99m Technetium
Tissue engineering through the imitation of nature has the ability to deal with the crisis caused by the shortage of donor organs and tissues. With regard to the ethical problems of extraction of embryonic stem cell, the...
Improved Differentiation of Mesenchymal Stem Cells into Hepatocyte-like Cells using FGF4 and IGF-1 in 3D Culture
Human Umbilical Cord Mesenchymal Stem Cells (UCMSCs) are considered as an excellent candidate for cell therapy to treat end-stage liver disease. Fibroblast Growth Factor-4 (FGF4), Hepatocyte Growth Factor, and Insulin-li...
Factors Associated with Umbilical Cord Blood Derived Mononuclear Cells Banking in Morocco: A Preliminary Study
Umbilical cord blood (UCB) is commonly used as the main heamatopoietic stem cell (HSC) source for allogeneic transplantation. Immediately available when compared to bone marrow (BM), UCB is now widely processed and store...
Renal Transplantation from Donation After Circulatory Death Donors: Evolution of Strategies
Renal Transplantation from Donation After Circulatory Death Donors: Evolution of Strategies
Side Population Cells in Human Adenomyotic Lesions Display Characteristics of Endometrial Stem Cells
Introduction: The precise etiology and physiopathology of ademyosis is still unknown. The aim of this research is to investigate if stem cells are found in adenomyosis and to characterize the role of adenomyotic lesion-d...